KALV vs AAPL: Which Stock is Better?
Side-by-side comparison of Kalvista Pharmaceuticals Inc and Apple Inc in 2026
KALV
Kalvista Pharmaceuticals Inc
$19.56
AAPL
Apple Inc
$269.02
Key Metrics Comparison
| Metric | KALV | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.07B | N/A | KALV |
| P/E Ratio | N/A | 33.68 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | 0.3% | 0.2% | KALV |
| Gross Margin | 25.7% | 47.3% | AAPL |
Analyze KALV
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KALV or AAPL a better investment?
Comparing KALV and AAPL: Kalvista Pharmaceuticals Inc has a market cap of $1.07B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KALV and AAPL?
KALV (Kalvista Pharmaceuticals Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KALV or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KALV or AAPL?
KALV has higher revenue growth at 0.3% vs 0.2% for AAPL.
Which company is more profitable: KALV or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 25.7% for KALV.
Which is the larger company: KALV or AAPL?
Kalvista Pharmaceuticals Inc (KALV) is larger with a market cap of $1.07B compared to N/A for AAPL.
Should I buy KALV or AAPL in 2026?
Both KALV and AAPL have investment merit. KALV trades at $19.56 while AAPL trades at $269.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KALV and AAPL stock?
Key differences: Market Cap ($1.07B vs N/A), P/E Ratio (N/A vs 33.7x), Revenue Growth (0.3% vs 0.2%), Gross Margin (25.7% vs 47.3%).